You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small renal mass

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Renal Mass, Kidney Tumor Trial in Chapel Hill (Small Renal Mass Biopsy, No Small Renal Mass Biopsy)

Recruiting
  • Small Renal Mass
  • Kidney Tumor
  • Small Renal Mass Biopsy
  • No Small Renal Mass Biopsy
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Mar 22, 2022

Active Surveillance of the Small Renal Mass

Completed
  • Small Renal Mass, Kidney Cancer
    • New Haven, Connecticut
      Yale New Haven Hospital Smilow Cancer Center
    Feb 26, 2021

    Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for

    Not yet recruiting
    • Kidney Tumor
    • +2 more
      • (no location specified)
      Feb 6, 2023

      Colorectal Cancer (CRC), NSCLC (NSCLC) Trial (an enriched high protein and high energy oral nutrition supplement (ONS))

      Not yet recruiting
      • Colorectal Cancer (CRC)
      • Non-small Cell Lung Cancer (NSCLC)
      • an enriched high protein and high energy oral nutrition supplement (ONS)
      • (no location specified)
      Dec 5, 2022

      Kidney Tumor Trial in Baltimore

      Recruiting
      • Kidney Neoplasm
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Oct 14, 2021

        Renal Malignant Tumor Trial in Indianapolis (Contrast enhanced ultrasound with Lumason)

        Recruiting
        • Renal Malignant Tumor
        • Contrast enhanced ultrasound with Lumason
        • Indianapolis, Indiana
          Indiana University Hospital
        Jul 12, 2022

        Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

        Completed
        • Clear Cell Renal Cell Carcinoma
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Feb 6, 2023

        Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)

        Not yet recruiting
        • Lung Non-Small Cell Carcinoma
        • +3 more
        • Biospecimen Collection
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Apr 13, 2023

        Subclass of Donor-specific Antibody asRisk Factor of Antibody

        Active, not recruiting
        • Antibody-mediated Rejection
          • Montpellier, Hérault, France
            CHU Lapeyronie
          Jan 18, 2023

          Renal Malignant Tumor, Renal Tumor Trial in Saint Petersburg (Normotonic partial nephrectomy, Hypotonic partial nephrectomy)

          Completed
          • Renal Malignant Tumor
          • Renal Tumor
          • Normotonic partial nephrectomy
          • Hypotonic partial nephrectomy
          • Saint Petersburg, Russian Federation
            State University Clinic
          May 24, 2022

          Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

          Recruiting
          • Small Cell Lung Cancer
          • Suzhou, Jiangsu, China
            The First Affiliated Hospital of Suzhou University
          Jul 19, 2022

          Loss of Autonomy in Elderly: Relationships Between Gut

          Not yet recruiting
          • Elderly Small Eater
          • Fecal and blood sampling and collection of nutritional, cognitive and sensorimotor data
          • +6 more
          • Dijon, France
            Chu Dijon Bourgogne
          Jul 4, 2022

          Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)

          Completed
          • Breast Cancer
          • Nonsmall Cell Lung Cancer
          • Beijing, Beijing, China
            Beijing GoBroad Boren Hospital
          May 5, 2023

          Profiling of Pembrolizumab and Nivolumab in Melanoma and/or

          Active, not recruiting
          • Lung Non-Small Cell Carcinoma
          • Melanoma
          • Biospecimen Collection
          • +2 more
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Feb 13, 2023

          Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

          Recruiting
          • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
          • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
          • Shanghai, Shanghai, China
            Shanghai Renji Hospital
          Sep 12, 2023

          NSCLC Trial in Guangzhou (ICI, Chemotherapy, Placebo)

          Recruiting
          • Non-small Cell Lung Cancer
          • Guangzhou, Guangdong, China
            Guangdong Provincial Hospital of Traditional Chinese Medicine
          Aug 11, 2022

          Skeletal Muscle Mass and Severity of Polycystic Liver Disease

          Enrolling by invitation
          • Polycystic Kidney Diseases
          • +2 more
          • Renal artery embolization
          • Taipei, Taiwan
            NTUH
          Jan 18, 2022

          NSCLC, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma Trial (QEQ278)

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • +3 more
          • QEQ278
          • (no location specified)
          Jul 14, 2022

          Kidney Tumor, Renal Cancer Trial in New York (Decision Aid (DA) Web Tool, Institutional Pamphlet)

          Recruiting
          • Kidney Tumor
          • Renal Cancer
          • Decision Aid (DA) Web Tool
          • Institutional Pamphlet
          • New York, New York
            NYU Langone Health
          Nov 4, 2022

          Clear-Cell Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult Trial in Montreal,

          Active, not recruiting
          • Clear-Cell Metastatic Renal Cell Carcinoma
          • +4 more
          • Montreal, Quebec, Canada
          • +3 more
          Aug 2, 2022

          After Nephron Sparing Treatment of Small Renal Tumours

          Active, not recruiting
          • Renal Cell Carcinoma
          • Quality of Life
          • CT-guided cryoablation
          • Partial nephrectomy
          • Odense C, Denmark
          • +1 more
          Feb 1, 2022

          Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

          Recruiting
          • Non Small Cell Lung Cancer
          • Mesothelioma
          • 's-Hertogenbosch, Netherlands
          • +4 more
          Sep 9, 2022

          Method With Gradient Glycosylation by Mass Spectrometry

          Active, not recruiting
          • Rheumatoid Purpura
          • Pediatric ALL
          • Mass Sepctrometry
          • Montpellier, France
          • +1 more
          Mar 8, 2022

          Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

          Terminated
          Has Results
          • Clear Cell Renal Cell Carcinoma
          • +3 more
          • Buffalo, New York
          • +1 more
          Aug 11, 2022

          Melanoma, Renal Cell Carcinoma, NSCLC Trial in United States (HBI-8000 in combination with nivolumab)

          Active, not recruiting
          • Melanoma
          • +2 more
          • HBI-8000 in combination with nivolumab
          • Phoenix, Arizona
          • +5 more
          Jun 11, 2022